NDC 57718-280-01 - MIZON COLLAGEN POWER FIRMING ENRICHED CREA M
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 57718-280
- Requested NDC
- 57718-280-01
- Package NDCs from labels
- 57718-280-01, 57718-280-02
- Manufacturer
- MIZON CO.,LTD. | Coson Co., Ltd._Osan Plant
- Effective date
- 2018-07-24
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Adenosine - MIZON CO.,LTD. | Coson Co., Ltd._Osan Plant | MIZON CO.,LTD. | Coson Co., Ltd._Osan Plant | 2018-07-24 | HUMAN OTC DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 57718-280-02 | 2022-01-28 | C162847 | 48780-1 | d6a99b39-b751-a426-e053-dadaa90af4c2 | f9ef5a57-34c2-478a-a7bc-5f725e55a1b8 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 57718-280-01 | MIZON COLLAGEN POWER FIRMING ENRICHED CREA M | 50 mL in 1 CONTAINER | CREAM | 50 | 1 | |
| 57718-280-02 | MIZON COLLAGEN POWER FIRMING ENRICHED CREA M | 1 in 1 CARTON | CREAM | 1 | 1 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| THE SKIN HOUSE ROSE HEAVEN SERUM | ADENOSINE, NIACINAMIDE | NOKSIBCHO cosmetic Co., Ltd. | a21c72f8-00ff-0971-e053-2995a90a2f97 | 2020-03-30 | Warnings | K72T3FS567 |
| THE SKIN HOUSE Wrinkle CollagenEmulsion | ADENOSINE | NOKSIBCHO cosmetic Co., Ltd. | a21f1539-0022-3797-e053-2a95a90a5b92 | 2020-03-30 | Warnings | K72T3FS567 |
| Adenosine | ADENOSINE | Fresenius Kabi USA, LLC | 6785cf30-360f-409b-a4b2-fc910728f01f | 2018-12-04 | Warnings, Adverse reactions | K72T3FS567 |
| 65ec2bf2-c2b7-4974-8457-9385e0312469 | f9ef5a57-34c2-478a-a7bc-5f725e55a1b8 | 2018-07-24 | Warnings | 65ec2bf2-c2b7-4974-8457-9385e0312469 f9ef5a57-34c2-478a-a7bc-5f725e55a1b8 | ||
| Adenosine | ADENOSINE | Gland Pharma Limited | 1b701a86-3c4e-4c13-bf9e-aa9e73774c20 | 2018-02-20 | Warnings, Adverse reactions | K72T3FS567 |
| Adenosine | ADENOSINE | Gland Pharma Limited | ab2edabd-e57d-4754-9822-93bd17af9e88 | 2017-12-04 | Warnings, Adverse reactions | K72T3FS567 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.